Price T Rowe Associates Inc. MD Trims Stake in Avanos Medical, Inc. (NYSE:AVNS)

Price T Rowe Associates Inc. MD lessened its position in Avanos Medical, Inc. (NYSE:AVNS - Free Report) by 31.1% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 44,908 shares of the company's stock after selling 20,317 shares during the period. Price T Rowe Associates Inc. MD owned 0.10% of Avanos Medical worth $715,000 at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. Barclays PLC boosted its stake in shares of Avanos Medical by 446.2% during the 3rd quarter. Barclays PLC now owns 96,194 shares of the company's stock valued at $2,311,000 after purchasing an additional 78,583 shares in the last quarter. JPMorgan Chase & Co. boosted its stake in shares of Avanos Medical by 6.9% during the 3rd quarter. JPMorgan Chase & Co. now owns 69,571 shares of the company's stock valued at $1,672,000 after purchasing an additional 4,472 shares in the last quarter. Tributary Capital Management LLC boosted its stake in shares of Avanos Medical by 38.1% during the 4th quarter. Tributary Capital Management LLC now owns 893,008 shares of the company's stock valued at $14,217,000 after purchasing an additional 246,379 shares in the last quarter. Empowered Funds LLC boosted its stake in shares of Avanos Medical by 141.3% during the 4th quarter. Empowered Funds LLC now owns 153,834 shares of the company's stock valued at $2,449,000 after purchasing an additional 90,091 shares in the last quarter. Finally, New York State Teachers Retirement System boosted its stake in Avanos Medical by 4.0% during the fourth quarter. New York State Teachers Retirement System now owns 75,215 shares of the company's stock worth $1,197,000 after acquiring an additional 2,921 shares in the last quarter. Institutional investors own 95.17% of the company's stock.

Insiders Place Their Bets

In other news, SVP Kerr Holbrook sold 7,000 shares of the business's stock in a transaction that occurred on Thursday, March 6th. The shares were sold at an average price of $15.25, for a total transaction of $106,750.00. Following the completion of the transaction, the senior vice president now directly owns 82,047 shares of the company's stock, valued at $1,251,216.75. The trade was a 7.86% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 2.64% of the company's stock.

Wall Street Analyst Weigh In

Separately, StockNews.com raised shares of Avanos Medical from a "hold" rating to a "buy" rating in a research note on Wednesday, March 19th.

Avanos Medical Stock Down 2.7%

NYSE:AVNS traded down $0.35 during mid-day trading on Tuesday, hitting $12.75. 438,298 shares of the company's stock were exchanged, compared to its average volume of 350,327. Avanos Medical, Inc. has a one year low of $11.84 and a one year high of $25.36. The company has a debt-to-equity ratio of 0.12, a current ratio of 2.22 and a quick ratio of 1.46. The business has a fifty day moving average price of $13.38 and a 200 day moving average price of $15.92. The company has a market cap of $589.61 million, a PE ratio of 37.50 and a beta of 1.13.

Avanos Medical (NYSE:AVNS - Get Free Report) last issued its earnings results on Tuesday, May 6th. The company reported $0.26 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.19 by $0.07. The business had revenue of $167.50 million during the quarter, compared to analysts' expectations of $161.75 million. Avanos Medical had a net margin of 2.30% and a return on equity of 4.70%. The business's revenue for the quarter was up .8% compared to the same quarter last year. During the same period in the previous year, the company earned $0.22 earnings per share. Equities analysts predict that Avanos Medical, Inc. will post 1.32 EPS for the current year.

About Avanos Medical

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.